Biotechnology News

BEVERLY, Mass., July 14, 2009 (GLOBE NEWSWIRE) -- Cellceutix Corporation (OTCBB:CTIX) announced today that Dr. Samuel Danishefsky has agreed to serve on the Cellceutix Scientific Advisory Board...

Results Support Initiation of Phase 2 Program With Multiple Dose Subcutaneous Regimen Conference Call and Webcast At 4:30 pm ET Today BERKELEY, Calif.,...

ANN ARBOR, Mich., July 14, 2009 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of autologous adult stem cell treatments for severe chronic cardiovascular diseases,...

RALEIGH, N.C., July 14, 2009 (GLOBE NEWSWIRE) -- DARA BioSciences, Inc. (Nasdaq:DARA) releases, today, a summary highlighting preclinical data for DB959, its lead compound for Type 2 Diabetes (T2D)...

TEMPE, Ariz., July 14, 2009 (GLOBE NEWSWIRE) -- Capstone Therapeutics (Nasdaq:CAPS) announced today the completion of enrollment for the first of its two ongoing AZX100 Phase 2 pilot clinical trials...

DELÅRSRAPPORT JANUARI-JUNI 2009 FORTSATT FOKUS PÅ KÄRNPROJEKTEN Perioden januari-juni i korthet · Nettoomsättningen uppgick till 4,4 (7,2) MSEK, varav andra kvartalet 2,2 (5,5) MSEK · Periodens...

INTERIM REPORT JANUARY-JUNE 2009 CONTINUED FOCUS ON CORE PROJECTS The period January-June in brief • Net sales amounted to MSEK 4.4 (7.2), whereof the second quarter MSEK 2.2 (5.5) • Net loss...

SAN DIEGO, July 13, 2009 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka...

Q-Med AB invites to conference call regarding half year report January-June, 2009 Time: Thursday, July 23, 2009 at 11.30 a.m. CET. To join the conference: Swedish dial in number: + 46 (0)8 5052...

Q- Med inbjuder till telefonkonferens med anledning av halvårsrapport januari-juni 2009 Tid: Torsdag 23 juli kl. 11.30. Telefonnummer inom Sverige: 08-5052 0114 Telefonnummer inom UK: +44 (0)207...